| Drug Type AAV based gene therapy | 
| Synonyms AAV9-SOD1-shRNA (AveXis), AVXS-301 | 
| Target | 
| Action inhibitors | 
| Mechanism SOD1 gene inhibitors | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseDiscontinuedDiscovery | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Discovery | United States  | - | |
| Motor Neuron Disease | Discovery | United States  | - | 





